Larvol Delta - Phase-1-Safety-and-Tolerability-of-BLX7006-a-Novel-Oral-SmallMolecule-GLP1-Receptor-Agonist

BLX 7006 - Biolexis Therap

https://planion.events/e/tos/ow2026/sessions/2360233/

Jeremiah Bearss

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next